DocDollars

Eyevance Pharmaceuticals LLC

TX · United States · Reporting entity ID 100000501814

Total reported 2019–2025
$3.74M
#805 of 2,960 reporting companies — 0% of all reported industry payments
$1.93M in general payments across 20,805 records.

How it breaks down

General payments $1,927,398
Ownership & investment $1,808,700

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Eyevance Pharmaceuticals LLC reported $3.74M to US doctors and teaching hospitals from 2019 to 2025, ranking #805 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 20,805 general payment records were filed.

Common questions about Eyevance Pharmaceuticals LLC

How much has Eyevance Pharmaceuticals LLC paid US doctors?

Eyevance Pharmaceuticals LLC reported $3,736,098 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,927,398 in general payments and $1,808,700 in ownership and investment interests.

How does Eyevance Pharmaceuticals LLC rank among drug and device companies?

It ranks #805 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Eyevance Pharmaceuticals LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.